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Chemotactic stimulation of Dictyostelium cells results
in a transient increase in cGMP levels, and transient
phosphorylation of myosin II heavy and regulatory
light chains. In Dictyostelium, two guanylyl cyclases
and four candidate cGMP-binding proteins (GbpA±
GbpD) are implicated in cGMP signalling. GbpA and
GbpB are homologous proteins with a Zn2+-hydrolase
domain. A double gbpA/gbpB gene disruption leads to
a reduction of cGMP-phosphodiesterase activity and
a 10-fold increase of basal and stimulated cGMP
levels. Chemotaxis in gbpA±B± cells is associated with
increased myosin II phosphorylation compared with
wild-type cells; formation of lateral pseudopodia is
suppressed resulting in enhanced chemotaxis. GbpC is
homologous to GbpD, and contains Ras, MAPKKK
and Ras-GEF domains. Inactivation of the gbp genes
indicates that only GbpC harbours high af®nity
cGMP-binding activity. Myosin phosphorylation,
assembly of myosin in the cytoskeleton as well as
chemotaxis are severely impaired in mutants lacking
GbpC and GbpD, or mutants lacking both guanylyl
cyclases. Thus, a novel cGMP signalling cascade is
critical for chemotaxis in Dictyostelium, and plays a
major role in myosin II regulation during this process.
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Introduction
cAMP and cGMP are important signalling molecules in
prokaryotes and eukaryotes. These molecules are pro-
duced by cyclases, degraded by phosphodiesterases
(PDEs), and exert their functions by binding to speci®c
proteins. In prokaryotes, cAMP regulates gene expression
by binding to the cyclic nucleotide-binding (cNB) domain
of catabolic repressor transcription factors (Passner et al.,
2000). In eukaryotes, cAMP and cGMP regulate enzyme
and channel activity, mainly via cAMP- and cGMP-
dependent protein kinases or by direct binding of cGMP to
channels (Houslay and Milligan, 1997). Other recently
identi®ed targets are proteins of the Epac family; besides a
cAMP-binding region, these proteins contain a Rap1 or
Ras guanine exchange factor (GEF) domain (de Rooij
et al., 1998). In addition, some PDEs contain a GAF
domain, which is an unrelated cGMP-binding domain that
regulates PDE activity (Francis et al., 2000).
cAMP-dependent protein kinase appears to be a
universal target, even occurring in primitive eukaryotes.
Much less is known about the synthesis and function of
cGMP in lower eukaryotes. Yeast seems to lack cGMP
signalling, since the genome of Saccharomyces cerevisiae
does not appear to encode putative guanylyl cyclases or
proteins containing cGMP-binding domains. Guanylyl
cyclases have been identi®ed in Paramecium, Tetra-
hymena and Plasmodium, but the role of cGMP in these
organisms is not yet resolved (Linder et al., 1999).
In Dictyostelium, cGMP synthesis is stimulated by the
chemoattractants cAMP and folic acid, which bind to
G-protein-coupled receptors (reviewed by Van Haastert
and Kuwayama, 1997). Guanylyl cyclase is activated for
only a few seconds, followed by adaptation of signal
transduction. The cGMP produced is degraded rapidly,
mainly by a cGMP-stimulated cGMP-speci®c PDE
(Van Haastert et al., 1982b). As a consequence of the
brief activation of guanylyl cyclases and cGMP stimula-
tion of PDE activity, cGMP accumulation is transient,
reaching a maximum at 10 s and returning to basal levels
after 30 s. It has been proposed that cGMP mediates
chemotaxis by modulating the phosphorylation and
localization of myosin II (reviewed by de la Roche and
Cote, 2001).
Myosin II is activated transiently after chemotactic
stimulation by two mechanisms. First, phosphorylation of
the regulatory light chain (RLC) increases the ATPase
activity of myosin II. Secondly, myosin II is recruited to
the cytoskeleton, a process regulated by phosphorylation
of myosin heavy chain (MHC) at three threonines located
in the coiled-coil tail (see Berlot et al., 1987; Vaillancourt
et al., 1988; Egelhoff et al., 1993; de la Roche and Cote,
2001). Cells have a decreased chemotactic index when the
gene encoding MHC is disrupted, or replaced by a mutant
gene converting the three threonines to alanines, which
results in the constitutive overassembly of MHC into the
cytoskeleton (Wessels et al., 1988; Egelhoff et al., 1993;
Stites et al., 1998). Cells expressing a mutant RLC with an
alanine at the phosphorylated serine also show defects in
chemotaxis (Zhang et al., 2002).
Studies with mutants suggest that cGMP signalling
plays a critical role in orchestrating these changes in
myosin phosphorylation and localization. In stmF mutants,
which make increased amounts of cGMP in response to
chemoattractants, MHC and RLC phosphorylation are
delayed or enhanced, while in KI-10 mutants, which do not
produce cGMP in response to chemoattractants, no
changes in RLC and MHC phosphorylation or trans-
location of myosin to the cytoskeleton are observed (Liu
et al., 1993; Liu and Newell, 1994; Dembinsky et al.,
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1996). However, the relationship between myosin
regulation, cGMP formation and chemotaxis is compli-
cated by the fact that the impaired genes of both stmF and
KI-10 have not been identi®ed. To understand the function
of cGMP in Dictyostelium, it is essential to identify the
genes that encode cGMP-metabolizing enzymes and
cGMP target proteins.
Recently, we characterized two unusual guanylyl
cyclases in Dictyostelium, GCA and sGC, that are not
related to vertebrate guanylyl cyclases, but are homo-
logous to 12-transmembrane and soluble adenylyl cyclase,
respectively (Roelofs et al., 2001a, b). We have also
identi®ed four genes that encode proteins with putative
cGMP-binding domains, GbpA±GbpD (Goldberg et al.,
2002). Here we use gene disruptions to show that GbpA
and GbpB encode novel cGMP-stimulated PDEs and are
thus involved in controlling the cGMP signal. GbpC and
GbpD encode putative cGMP target proteins containing
domains homologous to Ras, a protein kinase and Ras-
GEF. Mutants defective in guanylyl cyclase activity or
cGMP targets show impaired regulation of myosin II,
while computer-assisted motion analysis indicates that
these mutants are defective in chemotaxis.
Results
Gene inactivation
The genes encoding GbpA±GbpD were disrupted by
homologous recombination in the Dictyostelium uracil
auxotroph DH1. Four single and two double knock-outs
(gbpA and gbpB, and gbpC and gbpD) were made in this
strain by using two selection markers, Bsr and pyr5/6. The
positions of disruption of the open reading frames (ORFs)
are indicated in Figure 1. Knock-out strains were identi®ed
by PCR and con®rmed by Southern blot analysis (data not
shown). In Dictyostelium, the interruption of a gene with a
selection marker often leads to the absence of the
(truncated) mRNA, probably because it is unstable. This
was observed on northern blots for disruption of gbpA,
gbpB and gbpD. In contrast, gbpC± null cells show high
expression of the truncated mRNA, which may lead to
expression of truncated proteins (data not shown).
Therefore, for this study, we made a disruption of the
gbpC gene resulting in a 2.5 kb deletion at the beginning of
the ORF (see Figure 1). The phenotypes of the mutants are
described below in the section on chemotaxis.
cGMP-stimulated cGMP-speci®c
phosphodiesterase activity
Dictyostelium contains at least two cGMP PDE activities,
one from the cloned DdPDE3 (Kuwayama et al., 2001)
and a second enzyme that has been characterized
biochemically as cGMP PDE that is stimulated by the
analogue 8-bromo-cGMP (8bcGMP) (Van Haastert et al.,
1982b). GbpA and GbpB contain a Zn2+-hydrolase domain
that is distantly related to class II PDEs (Goldberg et al.,
2002). To test whether gbpA and/or gbpB encode a PDE,
we analysed gbp-null strains developed till the tight
aggregate stage when both genes are expressed at high
levels. Table I shows the PDE activity measured with
[3H]cAMP or [3H]cGMP in the absence or presence of
8bcAMP and 8bcGMP. Wild-type cells contain signi®cant
cGMP PDE activity that is stimulated 2- to 3-fold by
8bcGMP, but not by 8bcAMP. Wild-type cells also
contain a cAMP PDE activity that is stimulated by both
8bcAMP and 8bcGMP. These enzyme activities are not
signi®cantly different in lysates from gbpC±D± cells (data
not shown). gbpA± cells show a strong decrease of cGMP
PDE activity, and 8bcGMP no longer stimulates the
remaining enzyme activity; in contrast, cAMP PDE
activity is not changed in gbpA±. On the other hand, the
cGMP PDE activity is not strongly reduced in gbpB± cells,
in contrast to the signi®cant reduction of cAMP PDE
activity. In gbpA±/B± cells, the activity of both cGMP PDE
and cAMP PDE is low, and they are not activated by
8bcAMP and 8bcGMP. These results suggest that GbpA
and GbpB are PDEs
Dictyostelium contains several PDE activities besides
GbpA and GbpB that are still present in the gbpA± and
gbpB± cells. GbpA and GbpB may be characterized by
calculating the difference of PDE activity between the
appropriate cell lines. Thus, GbpA PDE activity is de®ned
as the difference in PDE activity observed in wild-type
cells and gbpA± cells, or the difference in activity in gbpB±
and gbpA±B± cells (Table I). This demonstrates that GbpA
is a cGMP-speci®c PDE that is stimulated by 8bcGMP but
not by 8bcAMP; cAMP is not hydrolysed by GbpA. These
properties are essentially identical to those of the
cGMP-stimulated cGMP PDE characterized previously
(Van Haastert and Van Lookeren Campagne, 1984). GbpB
PDE activity is de®ned as the difference in PDE activity
between wild-type and gbpB± cells, or between gbpA± and
gbpA±B± cells (Table I). This reveals that GbpB preferen-
tially hydrolyses cAMP while cGMP is hydrolysed at an
~4-fold lower rate; both 8bcAMP and 8bcGMP stimulate
the enzyme. These properties have been con®rmed by
overexpressing GbpB in gbpA±B± cells (L.Bosgraaf,
H.Russcher, H.Snippe, S.Bader, J.Wind and P.J.M.Van
Haastert, submitted for publication).
Figure 2A reveals the effect of disruption of gbpA and
gbpB on cAMP-stimulated cGMP levels in vivo. Wild-
type cells show a rapid increase in cGMP levels from a
basal level of ~1 pmol/107 cells to 6 pmol/107 cells 10 s
after stimulation; basal levels are recovered after ~30 s.
Fig. 1. Four unusual putative cGMP-binding proteins in Dictyostelium.
Schematic of the topology of GbpA±GbpD. The positions of disruption
of the protein sequences in the knock-out cell lines are indicated by
asterisks. The bar refers to 100 amino acids. GbpA and GbpB have the
same domain topology; a Zn2+-hydrolase (red) and two cNB domains
(blue). GbpC and GbpD are also homologues, sharing an N-terminal
Ras-GEF-associated domain (light green) a Ras-GEF domain (green), a
GRAM domain (dark blue) and two cNB domains (blue). GbpC has
additional N-terminal sequence containing leucine-rich repeats (yel-
low), a Ras (orange), a MAP kinase kinase kinase (pink) and a DEP
(turquoise) domain.
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This cGMP response is nearly identical in gbpB± cells, but
is strongly enhanced in gbpA± cells, with basal cGMP
levels of 3 pmol/107 cells and the response increased to
15 pmol/107 cells; basal levels are recovered after ~120 s.
The increased cGMP response in vivo is consistent with
the reduced cGMP PDE activity in vitro, con®rming that
gbpA encodes the cGMP-stimulated cGMP PDE activity.
Disruption of gbpB leads to only a slight increase of
cGMP levels. However, disruption of gbpB in a gbpA±
background results in a very pronounced increase in basal
cGMP levels from 3 pmol/107 cells in gbpA± to 12 pmol/
107 cells in gbpA±B±. The cAMP-induced cGMP response
is also substantially enhanced and prolonged from a
maximum of 15 pmol/107 cells at 10 s after stimulation
in gbpA± to 40 pmol/107 cells at 30 s after stimulation in
gbpA±B±; basal levels were reached after ~3±4 min. These
results con®rm the observation that gbpB encodes an
enzyme with low cGMP PDE activity that becomes
apparent when the much more active GbpA enzyme is
deleted.
cAMP- and cGMP-binding capacity
The cNB domains of GbpA±GbpD are potential cGMP-
binding sites, but may also bind cAMP or other com-
pounds. The binding of 10 nM cAMP or cGMP to lysates
from different null cell lines is presented in Figure 3. The
binding of cAMP to the cytosolic fraction of wild-type
cells and the two double-null strains gbpA±B± and gbpC±D±
is essentially identical (Figure 3A), indicating that the Gbp
proteins do not comprise a large fraction of the observed
cAMP-binding capacity. The binding of 10 nM cGMP is
not affected much by disruption of gbpA, gbpB or gbpD,
whereas disruption of gbpC results in a 80±90% reduction
in cGMP binding (Figure 3B).
Analysis of the af®nity and number of cGMP-binding
sites in different gbp-null mutants is presented as
Scatchard plots (Figure 4). The slope in these curves
indicates the af®nity, whereas the intercept with the
abscissa refers to the number of binding sites. Wild-type
cells, as well as mutants gbpA±B± and gbpD±, show non-
linear Scatchard plots. Curve ®tting with a two-component
model indicates the presence of ~200 fmol/mg protein
high af®nity cGMP-binding sites with a Kd of ~4 nM, and
~1200 fmol/mg protein low af®nity cGMP-binding sites
with a Kd of ~250 nM. The ®gure clearly demonstrates that
lysates from gbpC± and gbpC±D± cells have lost high
af®nity cGMP-binding sites. Residual cGMP binding is
very low, which complicates its analysis. Curve ®tting
statistics indicate that data should be ®tted according to a
one-component model, yielding low af®nity cGMP-bind-
ing sites with a capacity of ~1200 fmol/mg protein and a
Kd of ~500 nM (for statistics see legend of Figure 4).
The consequence of gbpC and gbpD disruption on the
cAMP-mediated cGMP response is presented in Figure 2B,
revealing essentially normal cGMP responses in the
gbpC±, gbpD± and gbpC±D± cells.
Myosin II phosphorylation and assembly
cGMP signalling is implicated in controlling myosin II
phosphorylation and localization during chemotaxis, but
Fig. 2. cGMP response in gbp-null cells. The cell were starved for 5 h
followed by stimulation with 0.1 mM cAMP. Responses were termin-
ated with perchloric acid, and cGMP levels were measured. (A) The
symbols refer to wild-type DH1 (®lled circles); gbpA± (open triangles);
gbpB± (open squares); and gbpA±B± (closed squares). (B) Wild-type
DH1 (®lled circles); gbpC± (open inverted triangles); gbpD± (open
circles); and gbpC±D± (®lled inverted triangles). Identical data are pre-
sented for wild-type DH1 in (A) and (B). The results shown are the
means of triplicate determinations from a typical experiment repeated
once.
Table I. PDE activity in Dictyostelium mutants
Cell lines PDE activity (pmol/min/mg)
cAMP cGMP
± 8bcAMP 8bcGMP ± 8bcAMP 8bcGMP
Wild-type 2.90 6 0.08 4.07 6 0.20 3.91 6 0.13 5.04 6 0.28 5.44 6 0.31 11.5 6 0.59
gbpA± 2.90 6 0.12 4.36 6 0.20 3.63 6 0.14 2.90 6 0.13 3.42 6 0.10 3.17 6 0.06
gbpB± 1.58 6 0.03 1.64 6 0.10 1.62 6 0.10 4.32 6 0.13 4.51 6 0.19 11.0 6 0.41
gbpA±B± 1.62 6 0.10 1.61 6 0.06 1.71 6 0.12 2.51 6 0.19 2.45 6 0.12 2.57 6 0.25
Characterization of GbpA
Wild-type ± gbpA± <0.15 <0.28 <0.20 2.14 6 0.31 2.02 6 0.33 8.31 6 0.59
gbpB± ± gbpA±B± <0.10 <0.11 <0.16 1.80 6 0.23 2.06 6 0.23 8.43 6 0.48
Characterization of GbpB
Wild-type ± gbpB± 1.32 6 0.09 2.43 6 0.21 2.29 6 0.17 0.72 6 0.31 0.93 6 0.36 <0.72
gbpA± ± gbpA±B± 1.28 6 0.16 2.75 6 0.21 1.92 6 0.18 0.38 6 0.22 0.97 6 0.16 0.60 6 0.26
PDE activity was measured in the lysates from tight aggregates with 10 nM [3H]cAMP or [3H]cGMP as substrate in the absence or presence of the
activators 8bcAMP or 8bcGMP. The data shown are the means and standard error of triplicate determinations from two experiments. The activity of
GbpA was deduced by subtraction of the activities of two cell lines that have the same mixture of PDE enzymes except GbpA. The < sign means that
the difference in activity is lower than the standard deviation.
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the mechanism of this regulation is as yet largely
unknown. By isolating genetically engineered mutants in
guanylyl cyclases (Roelofs and Van Haastert, 2002),
cGMP PDEs and cGMP target proteins, we are now able to
test the role of cGMP in myosin II regulation more
directly.
In wild-type cells, cAMP induces the transient phos-
phorylation of RLC and MHC, yielding maximal values at
~30 and 90 s after stimulation, respectively. (Figure 5).
Quanti®cation of the blots for RLC phosphorylation
reveals a 2.41 6 0.09-fold increase over pre-stimulated
levels (Table II). In gbpA±B± cells, which have very high
basal and receptor-stimulated cGMP levels, the stimula-
tion of RLC phosphorylation is signi®cantly larger and
persists longer than in wild-type cells. In gca±/sgc± cells,
which lack cGMP formation, cAMP induces a very small
but statistically signi®cant 1.33 6 0.16-fold increase in
RLC phosphorylation; this stimulation shows approxi-
mately the same kinetics as in wild-type cells. The RLC
phosphorylation response is also very small in gbpC±D±
cells, which lack two cGMP target proteins; in addition,
basal phosphorylation of RLC in unstimulated cells was
consistently lower than in the other strains.
The cAMP stimulation of MHC phosphorylation shows
essentially the same characteristics as phosphorylation of
RLC, except that MHC phosphorylation attains a maxi-
mum at 90 s versus 30 s for RLC phosphorylation. In
addition, the MHC phosphorylation response in wild-type
cells is rather small; thus, the effects of the mutations are
less pronounced than for RLC phosphorylation (see
Table II). In the PDE mutant gbpA±B±, the response is
prolonged, whereas in the guanylyl cyclase mutant gca±/
sgc± and the cGMP target mutant gbpC±/gbpD± the
phosphorylation of MHC is signi®cantly less than in
wild-type cells.
About 50% of the myosin is found in the cytoskeleton of
wild-type cells; cAMP induces a small depletion at 10 s
which is followed by a transient increase of myosin in the
cytoskeleton with a maximum at ~90 s after stimulation
(Figure 6). A similar pattern, with an initial dissociation
followed by a slower association of myosin with the
cytoskeleton, was observed by Liu and Newell (1991),
whereas a transient association without an initial dis-
Fig. 5. cAMP-induced phosphorylation of myosin heavy chain II
(MHC) and regulatory light chain (RLC). Starved cells were incubated
with [32P]phosphate for 30 min, followed by stimulation with 1 mM
cAMP at t = 0 s. Samples were taken at the times indicated and
immunoprecipitated with antibodies against RLC and MHC. The
immunoprecipitates were analysed by SDS±PAGE and autoradio-
graphy. Typical experiments are presented and were repeated at least
once. A quantitative analysis of these data is presented in Table II.
Fig. 3. cAMP and cGMP binding to proteins from gbp-null cells. The
binding of 10 nM [3H]cAMP (A) or 10 nM [3H]cGMP (B) to the cyto-
solic fraction of wild-type DH1 and different null cell lines was
measured. The means and standard deviations of two (A) or three (B)
experiments with triplicate determinations are shown.
Fig. 4. Scatchard plot of cGMP binding to proteins from gbp-null cells.
The binding of different concentrations of [3H]cGMP to the cytosolic
fraction was determined. The symbols refer to wild-type DH1 (®lled
circles); gbpA±B± (®lled squares); gbpC± (open inverted triangles);
gbpD± (open circles); and gbpC±D± (®lled inverted triangles). Curve
®tting with a two-component model indicates two binding forms in
wild-type, gbpA±B± and gbpD± showing 200 6 35 fmol high af®nity
cGMP-binding sites/mg protein with a Kd of 3.9 6 1.5 nM and
1165 6 134 fmol low af®nity cGMP-binding sites/mg protein with a
Kd of 257 6 83 nM. Mutant gbpC± and double mutant gbpC±D± show
only a low af®nity cGMP binding component with 1235 6 333 fmol
cGMP-binding sites/mg protein with a Kd of 557 6 220 nM. The data
points shown are the means of two experiments with triplicate
determinations; the estimated binding constants are the means and
standard error of the data pooled from three cell lines (wild-type,
gbpA±B± and gbpD±) or two cell lines (gbpC± and gbpC±D±).
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sociation was observed by Berlot et al. (1987). Basal levels
of MHC in the cytoskeleton are much lower in gbpA±B±
cells (26 6 4% in gbpA±B±, compared with 53 6 5% in
wild-type). Addition of cAMP to gbpA±B± cells induces a
relatively large increase in myosin in the cytoskeleton,
with a maximum approaching the level seen in wild-type
cells. In gca±/sgc± and gbpC±D± cells, basal levels of
myosin in the cytoskeleton are somewhat lower than in
wild-type cells. Addition of cAMP does not lead to the
association of myosin in the cytoskeleton; instead a
transient depletion between 20 and 80 s after stimulation
was observed (Figure 6). Statistical analysis of the data
on myosin phosphorylation and recruitment to the
cytoskeleton indicates that the differences between the
wild-type and mutant strains are signi®cant (Table II).
Chemotaxis of mutants
Cell aggregation on ®lters is as rapid in gbpA±B± double-
null cells as in wild-type cells, but is delayed signi®cantly
in gbpC±D± and gca±/sgc± cells by ~3 h (Table III). All
strains eventually form fruiting bodies that have approxi-
mately the same size as in wild-type cells. The mutants
gbpC±D± and gca±/sgc± cells show a reduced chemotactic
response towards cAMP as measured with the semi-
quantitative small population assay (data not shown).
Quantitative data on cell locomotion and chemotaxis
were obtained by computer-assisted motion analysis of
cells in buffer (the basic motile behaviour) and in de®ned
spatial gradients of cAMP (Table III). The basic motile
behaviour of cells in buffer is signi®cantly different among
the three mutants when compared with wild-type cells.
Mutant cells are rounder, translocation velocity is reduced
by about half, and cells show an increased direction
change, which is a parameter that re¯ects the frequency of
turning. Traces of cells moving in a chemotactic gradient
are presented in Figure 7. It is evident that wild-type and
gbpA±B± cells exhibit a strong chemotactic response (all
cells move in a directed and persistent fashion up the
spatial gradient of cAMP), while gbpC±D± and gca±/sgc±
cells show impaired chemotaxis. During the chemotactic
response, wild-type cells extend lateral pseudopodia. The
cell traces reveal that these lateral pseudopodia are
suppressed in gbpA±B± cells. In contrast, gbpC±D± and
gca±/sgc± cells translocate in spatial gradients of cAMP at
dramatically reduced velocities and in all directions. In a
®eld of wild-type cells, ~90% of the cells exhibit a positive
chemotactic response, while only ~60% of gca±/sgc± or
gbpC±D± cells move in the direction of the gradient.
The quantitative data on cell movement in chemotactic
gradients are presented in Table III. The speed of
movement in the mutants is still signi®cantly slower than
in wild-type cells. Movement of wild-type cells exhibits a
Fig. 6. Association of MHC with the Triton-insoluble cytoskeleton.
Starved cells were stimulated with 1 mM cAMP at t = 0 s. At the times
indicated, 0.5% Triton was added, and lysates were separated into a
supernatant and a Triton-insoluble cytoskeleton. The levels of MHC
were determined by western blotting using antibody against MHC. The
means of two or three experiments are shown. A quantitative analysis
of these data is presented in Table II. The symbols refer to wild-type
DH1 (®lled circles); guanylyl cyclase gca±/sgc± null cells (open
triangles); cGMP phosphodiesterase gbpA±B± null cells (®lled inverted
triangles); and gbpC±D± null cells lacking two cGMP targets (open
squares).
Table II. Myosin II modi®cation in Dictyostelium mutants
Response Wild-type gca±/sgc± gbpA±B± gbpC±D±
RLC phosphorylation
Fold increase 2.41 6 0.09a 1.33 6 0.16a 3.16 6 0.37a 1.55 6 0.16a
% response 100 23 6 18b 153 6 47b 39 6 18b
MHC phosphorylation
Fold increase 1.34 6 0.07a 1.15 6 0.03a 1.39 6 0.05a 1.14 6 0.04a
% response 100 45 6 16b 115 6 31 NS 41 6 18b
MHC cytoskeleton (% of total)
Basal 52.8 6 5.3 49.4 6 4.6 NS 26.0 6 3.7c 37.1 6 3.7c
Stimulated increase 11.2 6 3.4a ±7.1 6 1.2a,b 25.5 6 4.3a,b ±7.3 6 2.5a,b
Phosphorylation data: the radioactivity incorporated into RLC and MHC was quanti®ed using a phosphoimager. The data are presented as fold
increase relative to unstimulated samples within the same experiment, using stimulated levels at 30, 60 and 90 s for RLC, and 60, 90 and 180 s for
MHC. The percentage response is de®ned as (fold increase ±1 in mutant)/(fold increase ±1 in wild-type). The statistical signi®cance was tested with
Students t-test. aThe fold increase is signi®cantly different from 1; bthe response in the mutant is signi®cantly different from the 100% response in
wild-type, all at P < 0.05; NS, not signi®cant.
Cytoskeleton data: the distribution of MHC between the Triton-insoluble cytoskeleton and the soluble fraction was determined as described in
Figure 6. Data are presented as the percentage of total myosin that is present in the cytoskeleton. The stimulated increase refers to the increase
observed relative to basal levels in the same experiment. For calculation of the increase, data are taken at 40±120 s for wild-type, 40±300 s for
gbpA±B±, and 10±80 s for gca±/sgc± and gbpC±D± cells. The data shown are the means and standard deviations of 2±3 independent experiments. aThe
stimulated increase is signi®cantly different from 0; bthe increase in the mutant is signi®cantly different from the increase seen in wild-type cells,
cbasal levels are signi®cantly different from wild-type; all at P < 0.05.
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signi®cantly smaller direction change in the chemotactic
gradient in comparison with movement in buffer. The
reduction in turning and increased persistence induced by
cAMP are also observed in gbpA±B± cells, but not in
gca±/sgc± and gbpC±D± cells. The chemotaxis index is a
measure of the ef®ciency of moving in the direction of the
chemotactic gradient. A chemotactic index of +1.00
re¯ects direct movement up a spatial gradient, and a
chemotactic index of 0.00 re¯ects random movement.
The chemotactic index of wild-type DH1 cells was
Fig. 7. Cell movement in cAMP gradients. Aggregation-competent cells were deposited in a chemotaxis chamber with a cAMP gradient pointing to
the right. Cells were videorecorded for 10 min at a rate of 15 frames per min. The cell perimeters were outlined and are presented for ®ve representa-
tive cells as a stack of successive outlines at 8 s interval. The ®rst outline is indicated by an asterisk. (A) Wild-type DH1 cells; (B) guanylyl cyclase
gca±/sgc± null cells; (C) cGMP phosphodiesterase gbpA±B± null cells; and (D) gbpC±D± cells lacking the two cGMP targets.
Table III. Cell aggregation, locomotion and chemotaxis in Dictyostelium mutants
Property Wild-type gca±/sgc± gbpA±B± gbpC±D±
Aggregation (n = 3) (n = 3) (n = 3) (n = 3)
Aggregation time (h) 8.2 6 1.0 11.5 6 1.5* 8.3 6 0.7 NS 11.2 6 1.3*
Locomotion in buffer (n = 23) (n = 13) (n = 23) (n = 19)
Speed (mm/min) 8.2 6 3 3.9 6 1.1*** 5.6 6 1.7** 4.1 6 1.2***
Roundness (%) 55 6 14 77 6 9*** 71 6 15** 71 6 15**
Direction change (°/min) 35.6 6 9.4 42.8 6 7.0* 47.4 6 8.1*** 52.7 6 10.7***
Chemotaxis (n = 31) (n = 36) (n = 31) (n = 37)
% positive cells 88 61 97 59
Chemotaxis index +0.46 6 0.29 +0.06 6 0.22*** +0.61 6 0.26* +0.05 6 0.12***
Speed (mm/min) 9.3 6 4.7 4.5 6 1.2*** 6.3 6 3.0** 3.5 6 1.4***
Roundness (%) 64 6 8 80 6 8*** 60 6 12 NS 77 6 11***
Direction change (°/min) 24.0 6 8.6a 39.1 6 11.2*** 29.6 6 12.4 NSa 53.2 6 13.4***
Cells were deposited on ®lter paper and allowed to develop till the onset of aggregation. For analysis of locomotion in buffer, cells were deposited on
a glass support. The chemotactic response of these cells was measured in a chemotaxis chamber with a spatial gradient of cAMP. Cells were
videorecorded for 10 min. The perimeter and the centroid of the cells were determined by computer-assisted analysis. This allows calculation of the
speed, roundness (ratio of the long and short axis of the cell), direction change and chemotactic index (the net distance moved towards the source of
chemoattractant divided by the total distance moved). The data are derived from 3±5 independent experiment; n = the number of cells analysed. The
statistical signi®cance with wild-type cells was calculated using a t-test; *P < 0.05; **P < 0.01; ***P < 0.001; NS, not signi®cant at P > 0.05.
aThe direction change in a spatial gradient is signi®cantly different from the direction change in buffer.
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+0.46 6 0.29 (Table III), which is within the range of other
wild-type strains (Varnum and Soll, 1984; Zhang et al.,
2002). The chemotactic index of gbpA±B± cells is
+0.61 6 0.26, which is signi®cantly larger than the
chemotactic index of wild-type cells (P < 0.05). The
suppression of lateral pseudopodia is suf®cient to explain
the increased chemotactic ef®ciency of gbpA±B± cells. In
contrast, the chemotactic ef®ciency of gbpC±D± and gca±/
sgc± cells is severely reduced. The chemotactic indices of
gbpC±D± and gca±/sgc± cells are +0.06 and +0.05,
respectively, very close to the value for random move-
ment. Poor chemotaxis can be caused by impaired
movement or by poor orientation in the gradient, or by
both. The fastest gbpC±D± and gca±/sgc± cells, which
crawled as fast as the slowest DH1 cells, exhibited an
average chemotactic index of +0.12, while the slowest
DH1 cells exhibited an average chemotactic index above
+0.24. Furthermore, the cell traces and the data show that
~40% of gbpC±D± and gca±/sgc cells move in the wrong
direction, supporting the conclusion that orientation in a
spatial gradient is defective.
Discussion
cGMP phosphodiesterases
GbpA and GbpB have, in addition to the two cNB
domains, a Zn2+-hydrolase domain. This domain is found
in many metal-dependent hydrolases (Car® et al., 1995),
such as b-lactamases, glyoxalases and type II PDEs from
yeast (Nikawa et al., 1987) and Dictyostelium (Lacombe
et al., 1986). Disruption of gbpA demonstrates that the
gene encodes the previously characterized cGMP-stimu-
lated cGMP PDE; cAMP does not activate the enzyme and
is not hydrolysed (Van Haastert et al., 1982a). GbpB
appears to encode a previously unrecognized dual-
speci®city enzyme with respect to both substrate and
activation. This conclusion is con®rmed by detailed
kinetic analysis of GbpB overexpressed in gbpA±B± null
cells: GbpB hydrolyses cAMP between 4- and 8-fold faster
than cGMP and is half-maximally activated by 0.7 mM
cAMP and 2.2 mM cGMP (L.Bosgraaf, H.Russcher,
H.Snippe, S.Bader, J.Wind and P.J.M.Van Haastert,
submitted for publication). We propose that GbpA and B
hydrolyse the substrate in the Zn2+-hydrolase domains,
whereas the cNB domains mediate activation by cAMP or
cGMP. It is intriguing that the biochemical properties of
GbpA are very similar to those of human cGMP-stimu-
lated PDE2 with respect to Km value and activation
mechanism, although the protein sequences are com-
pletely different. The catalytic domain of human PDE2
belongs to the large family of PDE class I enzymes, and
the cGMP-binding regulatory domain is unrelated to the
cNB domain of GbpA but belongs to the group of GAF
domains (Francis et al., 2000). The biochemical phenotype
of the gbpA± cells is similar to that of the chemically
mutated Dictyostelium stmF, which lacks the cGMP-
stimulated PDE activity (Ross and Newell, 1981; Van
Haastert et al., 1982b). We have analysed the gbpA gene
from strain NP368 and observed a transcript and no
mutation that could explain the absence of GbpA PDE
activity, such as the introduction of stop codons or
mutations in the proposed catalytic domain (unpublished
observations).
cGMP-binding target proteins
Wild-type cells contain ~200 fmol/mg protein cGMP-
binding sites with high af®nity (Kd of 4 nM) and
~1000 fmol/mg protein low af®nity sites with a Kd of
200±500 nM. The intracellular cGMP concentration rises
during stimulation to 5±10 pmol/107 cells, which is
equivalent to 1±2 mM, suggesting that both high and low
af®nity cGMP-binding sites are potentially functional
in vivo. High af®nity cGMP binding is lost in gbpC± cells,
indicating that at least one of the cNB domains of GbpC
encodes these high af®nity sites. Low af®nity cGMP-
binding activity of other gbp-null cells does not disappear
in a speci®c disruptant, which may indicate that multiple
Gbps have a low af®nity cGMP-binding site. In agreement
with this hypothesis, the experimentally determined cGMP
activation constant of GbpA PDE (Ka = 0.2 mM) and GbpB
PDE (Ka = 2 mM) implies that at least one of the cNB
domains of GbpA and GbpB bind cGMP with this low
af®nity.
cGMP regulation of myosin II
Myosin II has been implicated as the main target of cGMP
signalling in Dictyostelium cells (de la Roche and Cote,
2001). The identi®cation of the genes encoding the
guanylyl cyclases GCA and sGC (Roelofs and Van
Haastert, 2002), and the present identi®cation of the
gbpA±gbpD genes (Goldberg et al., 2002) as cGMP PDEs
and cGMP targets has allowed us to investigate the
importance of cGMP in regulating myosin II in vivo using
engineered mutants. The results show that cAMP-medi-
ated phosphorylation of RLC and MHC, and the associ-
ation of MHC with the cytoskeleton, are all altered in the
mutants compared with wild-type cells, suggesting that
these myosin responses are regulated by a common cGMP
signalling pathway.
Basal RLC phosphorylation levels are nearly identical
in wild-type and gbpA±B± cells, even though basal cGMP
levels in the mutant exceed the maximal level reached
during stimulation in wild-type cells. These data imply
that cGMP alone does not induce RLC phosphorylation,
but that receptor stimulation is needed. On the other hand,
cGMP probably promotes RLC phosphorylation, because
receptor-stimulated RLC phosphorylation is strongly
enhanced in gbpA±B± cells at longer times after cAMP
stimulation. During the ®rst 30 s after stimulation, the
increase in RLC phosphorylation in gbpA±B± cells is very
similar to that in wild-type cells. In wild-type cells,
however, RLC phosphorylation begins to decrease at ~30 s,
whereas it continues to increase until 90 s in gbpA±B± cells.
Liu and Newell (1994) observed a similar delay in the time
at which maximum RLC phosphorylation levels were
reached in stmF mutant cells, which also have enhanced
cGMP levels.
A possible requirement for cGMP in RLC phosphoryl-
ation was investigated further using gca±/sgc± cells.
Previously, Liu and Newell (1994) found no increase in
RLC phosphorylation in genetically isolated mutants
which make no cGMP in response to chemoattractant. In
contrast, we found a small but signi®cant 1.3-fold increase
in RLC phosphorylation, compared with a 2.4-fold
increase in wild-type cells, suggesting only a partial
requirement for cGMP in the chemoattractant-elicited
increase in RLC phosphorylation. Our data are consistent
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with a model where cGMP facilitates chemoattractant-
elicited RLC phosphorylation, but that other, cGMP-
independent, pathways are also involved. The difference
in our ®ndings compared with those of Liu and Newell
(1994) may be due to additional genetic lesions present in
the strains used in their studies.
GbpC±D± cells have low levels of basal RLC phos-
phorylation, and a reduced increase in RLC phosphoryl-
ation in response to chemoattractants. Since similar results
were obtained in gbpC± cells, we attribute these effects to
GbpC. The cNB domains are likely candidates for
receiving the cGMP signal. The Ras, MAPKKK and/or
Ras-GEF domains may transduce the cGMP signal, but
may also function to receive other input signals. In
Dictyostelium, RLC is phosphorylated by MLCK-A and
by one or more additional MLCKs which have not been
identi®ed. MLCK-A is a good candidate for mediating the
cGMP-dependent component of RLC phosphorylation,
since in crude lysates it is activated by cGMP (Silveira,
1998). Since MLCK-A is activated by phosphorylation by
an upstream kinase (Smith et al., 1996), GbpC might
directly phosphorylate MLCK-A, or GbpC might activate
a protein kinase cascade which results in MLCK-A
phosphorylation.
MHC association with the cytoskeleton
cAMP stimulation normally induces a minor transient
dissociation of myosin from the cytoskeleton at ~10 s,
followed by a more pronounced association of MHC with
the cytoskeleton, with a maximum at ~90 s after stimu-
lation (Liu and Newell, 1991). In gca±/sgc±, gbpC±D± and
gbpC± cells, myosin ¯ux in response to chemoattractant is
impaired, consisting of a major dissociation from the
cytoskeleton that is not followed by the association with
the cytoskeleton as in wild-type cells. These results
suggest that cGMP binding to GbpC has a major effect
on MHC phosphorylation and myosin assembly.
Threonine phosphorylation of MHC is known to induce
bending of MHC and hence dissociation of myosin II from
the cytoskeleton. This hypothesis seems paradoxical in
relation to the observation of receptor-stimulated MHC
phosphorylation and association of MHC with the
cytoskeleton in wild-type, and also to the reduced MHC
phosphorylation and dissociation of MHC from the
cytoskeleton in gca±/sgc±, gbpC±D± and gbpC± cells.
However, a simple correlation between MHC phosphoryl-
ation and recruitment to the cytoskeleton cannot be made,
because a substantial fraction of MHC phosphorylation
in vivo is on serine, not threonine, the function of which is
unknown (Berlot et al., 1987). Future studies measuring
threonine phosphorylation of MHC derived from the
cytoskeleton and the soluble fraction may elucidate the
mechanism by which GbpC regulates myosin II ®lament
formation.
Role of cGMP in chemotaxis
The gca±/sgc± double-null cells aggregate slowly and show
strongly reduced chemotactic activity, indicating that a
cGMP-based signal transduction pathway is critical for
chemotaxis. Deletion of the two PDEs, GbpA and GbpB,
results in enhanced cGMP levels and improved chemo-
taxis. Apparently, elevated cGMP levels do not disturb the
processing of chemotactic signals in a spatial gradient. A
similar conclusion was reached previously using the
mutant stmF with a defect of cGMP PDE activity similar
to that in gbpA± (Chandrasekhar et al., 1995). Cells with a
deletion of the two cGMP-binding targets, GbpC and
GbpD, show a strongly reduced chemotactic activity and
delayed cell aggregation. The magnitude of the defect is
similar to that in guanylyl cyclase null mutant cells,
suggesting that these cGMP targets mediate the critical
role of cGMP in chemotaxis.
Chemotaxis in a spatial gradient of cAMP is a complex
behaviour, including components such as speed of loco-
motion, orientation of new pseudopodia, suppression of
lateral pseudopodia and cell polarity. Detailed analysis of
the behaviour of the PDE mutant gbpA±B± in a spatial
gradient of cAMP suggests that enhanced chemotaxis is
not caused by an increase in the speed of movement, but
rather is due to the stronger suppression of lateral
pseudopodia leading to a more elongated morphology
and more persistent movement in the direction of the
increasing cAMP gradient. This behavioural phenotype
correlates with prolonged association of MHC with the
cytoskeleton and delayed phosphorylation of MHC and
RLC, and is consistent with the phenotype of stmF, which
also has increased levels of cortical myosin (Liu and
Newell, 1991). The behaviour of gca±/sgc± and gbpC±D±
null cells in chemotactic gradients suggests that the
chemotactic defect is caused in both strains by a combin-
ation of three main effects, a 50% reduction in the speed of
movement, less persistent movement and a strong reduc-
tion in the capacity to orient in the direction of a positive
gradient. Reduced persistence and reduced orientation are
associated with reduced polarity of the cells and depletion
of myosin II from the cytoskeleton. These results are
consistent with observations on phosphorylation-defective
MHC mutant cells, demonstrating that cGMP-regulated
phosphorylation of MHC is important for chemotactic
movement.
The phenotypes of the present mutants may be
compared with that of the previously characterized mutant
KI8, which exhibits very low activity of both guanylyl
cyclases GCA and sGC (Kuwayama et al., 1993). This
chemically mutagenized cell line was obtained in a screen
that started by ®rst isolating aggregation-minus clones and
then assaying the cells for the absence of chemotaxis
towards cAMP and folic acid. Since the guanylyl cyclase
double-null cells do ®nally aggregate, such a mutant
would not have been isolated in the screen for KI mutants.
This suggest that KI8 either has multiple independent
mutations, or has a mutation that affects both the cGMP
pathway and another pathway that together are essential
for chemotaxis. The latter hypothesis is consistent with the
view discussed above that cGMP plays a critical role
during chemotaxis in a network of other signalling
molecules.
On agar, gca±/sgc± and gbpC±D± null cells can eventu-
ally aggregate, as was also observed for myosin II mutants
with a deletion of MHC of RLC (see de la Roche and Cote,
2001). We observed that gca±/sgc± and sgc± null cells
aggregate poorly on a support under buffer. Furthermore,
the mutants require ~10-fold steeper gradients of cAMP to
induce a chemotactic response than are required for wild-
type cells (Roelofs et al., 2001a). Such steep gradients are
present at the mid phase of oscillatory signalling during
cGMP signalling and Dictyostelium chemotaxis
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cell aggregation on agar, but gradients are less steep at the
beginning and the end of the cAMP wave, in the
chemotaxis chamber, or during cell aggregation under
buffer. The signi®cant reduction of chemotactic sensitivity
explains the delay in cell aggregation of gca±/sgc± and
gbpC±D±, as well as the poor aggregation under buffer, and
is probably a severe disadvantage in the wild where cells
aggregate at the soil±water interface.
A model for cGMP signalling to myosin II
regulation and chemotaxis
We have found that cGMP activation of GbpC plays a
major role in regulating myosin II in response to
chemotactic stimulation. A model is emerging where
cAMP stimulation of cells results in transient activation
of the guanlyl cyclases GCA and sGC (Roelofs and
Van Haastert, 2002), leading to the accumulation of
cGMP. This cGMP is degraded rapidly by the PDEs GbpA
and GbpB; as a result, the increase in cGMP concentration
is transient, with a maximum at 10 s (Figure 8). cGMP
binds to a high af®nity cGMP-binding protein in vivo
(Van Haastert et al., 1982a), that is now identi®ed as
GbpC. cGMP binding to GbpC in vivo reaches a maximum
at ~15 s after stimulation followed by dissociation of the
complex with a half-time of ~90 s. Activated GbpC makes
a major contribution to RLC phosphorylation, which
reaches a maximum at ~30 s, and decays slowly to basal
levels at ~2±3 min after stimulation. Binding of cGMP to
GbpC is also needed for MHC phosphorylation and the
recruitment of myosin to the cytoskeleton. Myosin II
®lament formation plays a critical role in maintaining cell
shape and persistent translocation in a spatial gradient of
chemoattractant. By testing the role of cGMP in myosin
regulation using genetically engineered mutants, and
identifying GbpC as a key player, this study is an
important step towards elucidating the exact pathways
involved in regulating myosin II during chemotaxis.
Materials and methods
Strain and culture conditions
AX3 (wild-type), DH1 (a uracil auxotroph wild-type), gca±/sgc± (a
guanylyl cyclase-null cell line; Roelofs and Van Haastert, 2002) and the
mutant cell lines described below were grown in HG5 medium to a
density of ~2 3 106 cells/ml. When grown with selection, HG5 medium
was supplemented with 10 mg/ml blasticidin S. Cells were starved for up
to 6 h by shaking in 10 mM phosphate buffer pH 6.5 (PB) at a density of
107 cells/ml, or for longer periods on non-nutrient agar.
Gene disruption
To make disruptants of the gbp genes, the following strategy was used.
PCR primers (see below) were designed that would amplify a fragment of
0.5±1 kb with a unique restriction site approximately in the middle.
Genomic DNA was used as template for the PCR, and the ampli®ed DNA
was subcloned. The unique restriction site was used subsequently to
introduce either the Bsr (Sutoh, 1993) or the pyr5/6 selection cassette.
[The pyr5/6 cassette contains the coding region of the pyr5/6 protein
(Boy-Marcotte and Jacquet, 1982) that was ampli®ed by PCR and cloned
into a vector between the actin15 promoter and the actin 8 terminator.]
The resulting disruption plasmid was digested with restriction enzymes to
obtain the selection cassette with gbp ¯anking sequences, which was
puri®ed and ampli®ed by PCR with the primers that were used to obtain
the original gbp genomic fragment. Approximately 5 mg of the PCR
product was used to transform Dictyostelium DH1 cells by electropor-
ation. To select for transformants with the bsr cassette, HG5 was
supplemented with 10 mg/ml blasticidin, while transformants with the
pyr5/6 cassette were selected using uracil-de®cient FM medium. Potential
knock-outs were screened by PCR and con®rmed by Southern and
northern blot analysis. The positions of interruption of the ORFs are
indicated in Figure 1.
For disruption of gbpA, the PCR primers TCATAGATCTAGAA-
GGTGATTATACAG and AGTTGGATCCATTGTTGCTAATTC were
used. The selection cassette was cloned into the MslI site of the 468 bp
PCR product. For gbpB, the PCR product was 900 bp using the primers
CCATTCTATGTGAAGTCAATC and AATTACTACTTACCAGCA-
CC. The pyr5/6 cassette was cloned in the BclI restriction site. The
PCR primers for gbpD were TCAAAGATTAGAGAAGAGAC and
TAGTTGAGCTTGAATTACAC. The 858 bp PCR product contained a
BglII restriction site used to incorporate the pyr5/6 cassette. Disruption of
gbpC was done slightly differently: the PCR primers ATCATT-
GATTTCGGTACAAG and TCTTCCTCTGTGAAAATATC were used
to obtain a 874 bp product; the Bsr cassette was introduced in the unique
BglII site. Subsequently, the primers TTGATCAATTTACCTCAATC
and TTCTAGACGATCACCTAAAATAC were used to obtain another
333 bp product, which was exchanged with the ®rst 426 bp of the 874 bp
product, in front of the Bsr resistance cassette. Homologous recombina-
tion introduces a 2.5 kb deletion of the gene.
Phosphodiesterase assay
Cells were starved until the tight aggregate stage, washed twice with PDE
lysis buffer (40 mM HEPES/NaOH, 0.5 mM EDTA pH 7.0) and
resuspended at a density of 108 cells/ml in PDE lysis buffer supplemented
with 0.25 M sucrose. Cells were lysed by passage through a 0.45 mm
Nuclepore ®lter. The lysate was centrifuged for 2 min at 14 000 g and the
supernatant was used.
The PDE assay mixture (®nal concentrations) contained assay buffer
(40 mM HEPES/NaOH pH 7.0, 0.5 mM EDTA, 0.25 M sucrose, 5 mM
MgCl2), 10 nM [3H]cGMP as substrate, 50 mM cAMP, 5 mM
dithiothreitol (DTT) and 30 ml of enzyme in a total volume of 100 ml;
the lysates were diluted to achieve between 10 and 30% hydrolysis of
cGMP. After incubation for 15 min at 22°C, reactions were terminated by
boiling for 1 min. The 5¢ GMP produced was dephosphorylated by calf
intestine phosphatase (CIP; 1 U of enzyme in 100 ml of CIP buffer
incubated for 1 h at 37°C). Finally, 300 ml of a 50% slurry of DOWEX
AG1X2 was added to remove remaining cGMP. After 15 min incubation
at 22°C, samples were centrifuged for 2 min at 14 000 g, and the
radioactivity in 200 ml of the supernatant was determined.
cGMP-binding assay
Cells were starved for 4 h and, after lysis as described above, the 14 000 g
supernatant was centrifuged for 1 h at 48 000 g. The newly obtained
supernatant was used in an assay containing assay buffer (20 mM HEPES/
NaOH, 0.25 mM EDTA, 50 mM phosphate buffer, 0.125 M sucrose,
3 mM MgCl2 pH 6.1), 5 mM DTT, 2±100 nM [
3H]cGMP, 0±1 mM
Fig. 8. Time course of the cGMP and myosin responses in wild-type
cells. The responses were calculated by ®rst subtracting basal levels of
unstimulated cells and are then expressed as a percentage of the maxi-
mal response. Data are from Figures 2, 5 and 6; the cGMP occupancy
of GbpC is taken from Van Haastert et al. (1982a). Symbols refer to
cGMP (open circles); phosphorylation of RLC (®lled triangles); phos-
phorylation of MHC (®lled inverted triangles); MHC in the cytoskele-
ton of wild-type cells (®lled squares); and MHC in the cytoskeleton of
gca±/sgc± and gbpC±D± cells (open squares). The cGMP occupancy of
GbpC is presented as a dotted line.
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unlabelled cGMP and 100 ml lysate in a total volume of 200 ml. After
15 min at 0°C, the mixture was ®ltered over nitrocellulose ®lters (pore
size 0.45 mm) and the ®lters were washed twice with 4 ml of ice-cold
50 mM phosphate buffer pH 6.1. The radioactivity associated with the
®lters was determined using a liquid scintillation counter. To determine
non-speci®c binding, 30 mM cGMP was included in the assay mixture.
cGMP response to cAMP
Cells were starved for 5 h, washed and resuspended in PB at a density of
108 cells/ml, and stimulated with 0.1 mM cAMP. The reactions were
terminated with an equal volume of 3.5% (v/v) perchloric acid at the
indicated time points. After neutralization with KHCO3 and centrifug-
ation, the cGMP content was determined by radioimmunoassay.
Phosphorylation of RLC and MHC
Cells were starved for 2 h in 20 mM MES, 0.2 mM CaCl2, 2 mM MgSO4
pH 6.8 at a density of 2 3 107 cells/ml, pulsed with cAMP (4 h with
100 nM cAMP at 10 pulses/h) and incubated for 30 min with 5 mM
caffeine to inhibit endogenous cAMP oscillations. Subsequently, cells
were incubated with [32P]orthophosphate (500 mCi per ml). Cells were
stimulated at t = 0 s with 1 mM cAMP and 10 mM DTT, and, at the
indicated time points, 200 ml samples were added to 10 ml of 20% SDS.
RLC and MHC were immunoprecipitated and subjected to SDS±PAGE as
described (Smith et al., 1996). The radioactivity on the gels was
quanti®ed using a phosphoimager.
Determination of myosin content in the Triton-insoluble
fraction
Cells were starved, treated with caffeine and stimulated with cAMP as
described above. At the indicated time points, 150 ml of the cell
suspension was added to 150 ml of ice-cold lysis buffer [180 mM MES
pH 6.8, 5 mM MgCl2, 1% Triton X-100, 100 mg/ml phenylmethylsulfonyl
¯uoride (PMSF), 1.5 mM TLCK, 100 mg/ml TAME, 80 mg/ml TPCK,
2 mg/ml pepstatin, 5 mg/ml leupeptin, 1 mM ATP], and incubated on ice
for 5 min. The samples were divided into a supernatant and a pellet
fraction by centrifugation at 14 000 g for 1 min. The pellet fractions were
dissolved in 40 ml of 23 sample buffer. The proteins in the supernatant
fractions were precipitated with 700 ml of acetone, collected after 10 min
on ice by centrifugation for 1 min at 14 000 g and dissolved with 40 ml of
23 sample buffer. Finally, the samples were boiled for 5 min and analysed
by PAGE and subsequent western blotting using anti-MHC antibody and
goat anti-rabbit IgG linked with horseradish peroxidase as a secondary
antibody. The chemiluminescence was quanti®ed using a phosphoimager.
Computer-assisted analysis of single cell chemotaxis in a
spatial gradient of cAMP
To initiate development, growth phase cells were washed in buffered salts
solution (BSS) containing 20 mM KCl, 2.5 mM MgCl2 and 20 mM
KH2PO4 pH 6.4, and dispersed on a black ®lter pad saturated with BSS at
a density of 5 3 106 cells per cm2. Amoebae were washed off the ®lter
pads at the ripple stage, which in dense cultures represents the onset of
aggregation, the time at which Dictyostelium amoebae attain their highest
average velocity (Varnum and Soll, 1984). In this case, the onset of
aggregation was observed between 8 and 11 h, depending on the
particular strain.
The motile behaviour of cells in buffer and in spatial gradients of
cAMP was analysed using computer-assisted methods previously
described (Soll, 1995; Soll et al., 2001). Brie¯y, cells were dispersed
on the bridge of a Plexiglas gradient chamber, in which one of the two
troughs bordering the bridge contained BSS and the other trough
contained BSS plus 10±6 M cAMP. Cells were videorecorded through a
253 objective with bright ®eld optics for a 10 min period following an
initial 5 min incubation period necessary to establish a steep gradient.
Images were digitized at a rate of 15 frames per min. 2D-DIAS software
then automatically outlined the cell perimeters and converted them to
b-spline replacement images from which the position of the cell centroid
was determined. The chemotactic index, speed and change of direction
were computed from the centroid position. The chemotactic index is the
net distance moved towards the source of chemoattractant divided by the
total distance moved in the same time period.
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